<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR6">
 <label>6.</label>
 <mixed-citation publication-type="other">Castagna A, Maggiolo F, Penco G, et al. Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and / or Elvitegravir- Resistant HIV-1 : 24-Week Results of the Phase III VIKING-3 Study. J Infect Dis. 2014;210. 10.1093/infdis/jiu051.</mixed-citation>
</ref>
